Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma (TSXV: NRX, OTCQB: NRXBF)

by /u/bullish_man_2091 in /r/CanadianStockExchange

Upvotes: 1

Favorite this post:

Mark as read:

Your rating:

Add this post to a custom list